Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Net Income Growth
104.86%
Quarterly · Period ending:
LCTX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported104.86%period ending
Latest reported104.86%period ending
LCTX Quarterly Net Income YoY % (0.00% → 104.86%)
Year-over-year change
High-resolution chart · PNG
LCTX net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 15.7725% | |
| 27.8957% | |
| 29.0241% | |
| 46.7411% | |
| -32.9761% | |
| -64.9934% | |
| -109.0909% | |
| -25% | |
| 27.2727% | |
| -10% | |
| 20% | |
| -120% | |
| 25% | |
| -42.8571% | |
| -100% | |
| 16.6667% | |
| -33.3333% | |
| -133.3333% | |
| 28.5714% | |
| 0% | |
| 0% | |
| 40% | |
| -75% | |
| -100% | |
| -50% | |
| -66.6667% | |
| -33.3333% | |
| -50% | |
| -33.3333% | |
| 0% | |
| -50% | |
| 0% |